Endogenous endophthalmitis secondary to subclinical pyelonephritis

Riya N Soni¹, Ariadna Perez-Sanchez², Robert Nathanson^{3

4}

Affiliations

¹ Department of Medicine, Division of Infectious Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.
² Hospital Medicine Section, Division of General Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA.
³ Division of Hospital Medicine, University of Texas Health San Antonio, San Antonio, Texas, USA.
⁴ Section of Hospital Medicine, South Texas Veterans Health Care System, San Antonio, Texas, USA.

Riya N Soni et al. J Hosp Med. 2026.

. 2026 Jan 20.

doi: 10.1002/jhm.70244. Online ahead of print.

Riya N Soni¹, Ariadna Perez-Sanchez², Robert Nathanson^{3

4}

¹ Department of Medicine, Division of Infectious Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.
² Hospital Medicine Section, Division of General Internal Medicine, Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah, USA.
³ Division of Hospital Medicine, University of Texas Health San Antonio, San Antonio, Texas, USA.
⁴ Section of Hospital Medicine, South Texas Veterans Health Care System, San Antonio, Texas, USA.

No abstract available

References

1. Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19(3):227‐234. doi:10.1111/1469-0691.12118
1. Sadiq MA, Hassan M, Agarwal A, et al. Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect. 2015;5(1):32. doi:10.1186/s12348-015-0063-y